Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Herbal supplement sales could be haulted in New York

New York's attorney general tells retailers to stop sales of herbal supplements after majority of them fail test to detect plant materials listed

Retailers GNC, Target, Walmart, and Walgreens, were ordered to stop the sale of certain herbal supplement products for allegedly selling store brand items in New York that either could not be verified to contain the labeled substance, or which were found to contain ingredients not listed on the labels.

The letters, sent by New York Attorney General Eric T. Schneiderman, call for the retailers to immediately stop the sale of certain popular products, including Echinacea, Ginseng, St. John’s Wort, and others.

In addition, he requested the companies provide detailed information relating to the production, processing and testing of herbal supplements sold at their stores, as well as set forth a thorough explanation of quality control measures in place.

The letters come as DNA testing, performed as part of an ongoing investigation by the attorney general’s office, allegedly shows that, overall, 79% of the test results from store brand herbal supplements did not haveDNA related to the labeled content or verifying contamination with other plant material.

The retailer with the poorest showing for DNA matching products listed on the label was Walmart. Of those tested, 4% of the Walmart products showed DNA from the plants listed on the products’ labels.

To put that into context, overall, 21% of the test results from store brand herbal supplements verified DNA from the plants listed on the products’ labels.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?